Eyenovia Statistics
Total Valuation
Eyenovia has a market cap or net worth of $9.72 million. The enterprise value is $16.93 million.
Important Dates
The last earnings date was Monday, May 19, 2025, after market close.
| Earnings Date | May 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Eyenovia has 2.88 million shares outstanding. The number of shares has increased by 127.93% in one year.
| Current Share Class | 2.88M |
| Shares Outstanding | 2.88M |
| Shares Change (YoY) | +127.93% |
| Shares Change (QoQ) | +80.29% |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 10.10% |
| Float | 2.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 62.04 |
| Forward PS | 1.82 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 252.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34
| Current Ratio | 0.34 |
| Quick Ratio | 0.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.69 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -117.74% |
| Return on Invested Capital (ROIC) | -190.44% |
| Return on Capital Employed (ROCE) | 332.31% |
| Revenue Per Employee | $4,790 |
| Profits Per Employee | -$3.03M |
| Employee Count | 14 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.40% in the last 52 weeks. The beta is 1.00, so Eyenovia's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -94.40% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 14.47 |
| Relative Strength Index (RSI) | 61.87 |
| Average Volume (20 Days) | 7,441,086 |
Short Selling Information
The latest short interest is 166,697, so 5.78% of the outstanding shares have been sold short.
| Short Interest | 166,697 |
| Short Previous Month | 59,054 |
| Short % of Shares Out | 5.78% |
| Short % of Float | 5.81% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, Eyenovia had revenue of $67,063 and -$42.38 million in losses. Loss per share was -$34.33.
| Revenue | 67,063 |
| Gross Profit | -6.52M |
| Operating Income | -30.29M |
| Pretax Income | -32.44M |
| Net Income | -42.38M |
| EBITDA | -29.13M |
| EBIT | -30.29M |
| Loss Per Share | -$34.33 |
Full Income StatementBalance Sheet
The company has $3.93 million in cash and $11.15 million in debt, giving a net cash position of -$7.21 million or -$2.50 per share.
| Cash & Cash Equivalents | 3.93M |
| Total Debt | 11.15M |
| Net Cash | -7.21M |
| Net Cash Per Share | -$2.50 |
| Equity (Book Value) | -9.71M |
| Book Value Per Share | -3.43 |
| Working Capital | -9.94M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$24.67 million and capital expenditures -$47,372, giving a free cash flow of -$24.72 million.
| Operating Cash Flow | -24.67M |
| Capital Expenditures | -47,372 |
| Free Cash Flow | -24.72M |
| FCF Per Share | -$8.57 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -45,172.74% |
| Pretax Margin | -63,194.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Eyenovia does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -127.93% |
| Shareholder Yield | -127.93% |
| Earnings Yield | -436.23% |
| FCF Yield | -254.44% |
Analyst Forecast
The average price target for Eyenovia is $2.00, which is -40.65% lower than the current price. The consensus rating is "Hold".
| Price Target | $2.00 |
| Price Target Difference | -40.65% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 3, 2025. It was a reverse split with a ratio of 0.0125:1.
| Last Split Date | Feb 3, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0125:1 |
Scores
Eyenovia has an Altman Z-Score of -64 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -64 |
| Piotroski F-Score | 2 |